Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-03-15 Option Award | 2024-03-19 8:01 pm | N/A N/A | Tyra Biosciences Inc. | TYRA | Fuhrman Alan Chief Financial Officer | 932 | $12.48 | 2,395 (Direct) | View |
| 2023-09-15 Option Award | 2023-09-19 7:27 pm | N/A N/A | Tyra Biosciences Inc. | TYRA | Fuhrman Alan Chief Financial Officer | 1,463 | $12.5 | 1,463 (Direct) | View |
| 2023-07-28 Option Award | 2023-08-01 5:34 pm | N/A 2033-07-27 | Tyra Biosciences Inc. | TYRA | Fuhrman Alan Chief Financial Officer | 62,685 | $0 | 62,685 (Direct) | View |
| 2023-06-15 Option Award | 2023-06-16 4:09 pm | N/A 2033-06-15 | Esperion Therapeutics Inc. | ESPR | Fuhrman Alan Director | 26,150 | $0 | 51,404 (Direct) | View |
| 2023-05-24 Option Award | 2023-05-25 4:25 pm | N/A 2033-05-24 | SpringWorks Therapeutics Inc. | SWTX | Fuhrman Alan Director | 18,422 | $0 | 24,346 (Direct) | View |
| 2023-01-01 Option Award | 2023-01-03 5:01 pm | N/A 2032-12-31 | Tyra Biosciences Inc. | TYRA | Fuhrman Alan Chief Financial Officer | 360,800 | $0 | 360,800 (Direct) | View |
| 2022-05-31 Disposition | 2022-05-31 10:02 am | N/A 2031-10-27 | Checkmate Pharmaceuticals Inc. | CMPI | Fuhrman Alan Director | 279,437 | $0 | 0 (Direct) | View |
| 2022-05-26 Option Award | 2022-05-27 4:12 pm | N/A 2032-05-26 | Esperion Therapeutics Inc. | ESPR | Fuhrman Alan Director | 20,000 | $0 | 20,000 (Direct) | View |
| 2022-05-19 Option Award | 2022-05-20 5:41 pm | N/A 2032-05-19 | SpringWorks Therapeutics Inc. | SWTX | Fuhrman Alan Director | 20,136 | $0 | 21,242 (Direct) | View |
| 2021-10-27 Option Award | 2021-10-29 6:54 pm | N/A 2031-10-27 | Checkmate Pharmaceuticals Inc. | CMPI | Fuhrman Alan See Remarks | 246,671 | $0 | 246,671 (Direct) | View |
| 2021-06-16 Option Award | 2021-06-21 9:22 pm | N/A 2031-06-16 | Checkmate Pharmaceuticals Inc. | CMPI | Fuhrman Alan Director | 10,030 | $0 | 10,030 (Direct) | View |
| 2021-05-27 Option Award | 2021-05-28 4:19 pm | N/A N/A | Esperion Therapeutics Inc. | ESPR | Fuhrman Alan Director | 12,376 | $0 | 25,254 (Direct) | View |
| 2021-05-20 Option Award | 2021-05-21 4:32 pm | N/A 2031-05-20 | SpringWorks Therapeutics Inc. | SWTX | Fuhrman Alan Director | 8,104 | $0 | 32,225 (Direct) | View |
Ownership | 2020-08-06 9:07 pm | N/A 2029-06-12 | Checkmate Pharmaceuticals Inc. | CMPI | Fuhrman Alan Director | 0 | $0 | 22,736 (Direct) | View |
| 2020-05-28 Option Award | 2020-05-29 4:41 pm | N/A N/A | Esperion Therapeutics Inc. | ESPR | Fuhrman Alan Director | 1,221 | $0 | 12,878 (Direct) | View |
| 2020-05-20 Option Award | 2020-05-22 4:38 pm | N/A 2030-05-20 | SpringWorks Therapeutics Inc. | SWTX | Fuhrman Alan Director | 7,464 | $0 | 7,464 (Direct) | View |
| 2020-05-15 Option Award | 2020-05-18 5:04 pm | N/A N/A | Esperion Therapeutics Inc. | ESPR | Fuhrman Alan Director | 11,003 | $0 | 11,657 (Direct) | View |
Ownership | 2020-03-18 08:07 am | N/A N/A | Esperion Therapeutics Inc. | ESPR | Fuhrman Alan Director | 0 | $0 | 654 (Direct) | View |
| 2019-09-12 Option Award | 2019-09-16 8:47 pm | N/A 2029-09-12 | SpringWorks Therapeutics Inc. | SWTX | Fuhrman Alan Director | 29,983 | $0 | 29,983 (Direct) | View |